What is Docuvera?
Docuvera is the most efficient way to create, review, update, and publish life sciences documentation.
Docuvera provides the perfect blend of AI-powered automation with the governance, consistency, and control required to serve the regulatory writing space. Achieve maximum efficiency in your content development while delivering higher quality and more accurate documents.
We solve one of biopharma’s major challenges: the inefficiency of creating, reviewing, updating, and publishing documentation throughout the drug development lifecycle.
What is Docuvera?
Docuvera is the most efficient way to create, review and publish Life Sciences documentation.
Docuvera is a single platform to author, review, approve, translate, and publish regulated documents by reusing approved, compliant component content. We solve one of biopharma’s major challenges – creating and updating documentation through the drug development lifecycle.
We work with the world’s best
AI + Structured Content
A new era of pharmaceutical documentation
There’s a dynamic duo transforming the face of the pharmaceutical industry. AI technology plus a structured content solution that offers the powerful controls and standardization mandatory for the highly regulated pharmaceutical world.
How our AI + structured content solution works
What can AI + structured content do for you?
Docuvera combines the automation of AI to deliver efficiency with the control and governance of structured content to transform how you do business.
When implemented effectively, Docuvera will slash the time needed to create documentation, dramatically increasing output without having to add staff members — making a major improvement to your bottom line.
Typical Docuvera customers see dramatic efficiency and productivity results:
82%
Content Reuse
Reuse approved content components versus rewriting or copy/pasting content
110%
Productivity Gains
Content reuse drives efficiency in creating, reviewing and updating documents
145%
ROI Achieved
Gains in efficiency allows existing teams to do more without having to add headcount
Demonstrated success
Eli Lilly led organizational change to realize successful component authoring with Docuvera
Achieving 65% reuse of components in Global Medical Information in the first year, Eli Lilly Global Medical Information has successfully made the paradigm shift from traditional authoring to component authoring. Hear the four important milestones in Lilly’s adaptive content creation journey and how they applied the 5W framework as a guide to help lead organizational change to component authoring.
Award winning solutions
TIN Report’s Absolute IT Supreme Scale-Ups for 2022
Technology Investment Network (TIN) has named ASC a winner of this year’s TIN Awards for the 2022 TIN Report in the category of Absolute IT Supreme Scale-Ups. As a leading innovator of authoring management platform tools including Docuvera, ASC has proven to be a very successful technology company for New Zealand and worldwide.
Remove the pain of cut and paste
Authors can collaborate simultaneously on documents by easily reusing approved blocks of content to assemble documents. No technical expertise or expensive support required.
Collaborative review and approval process
Cross-department review of documents can happen collaboratively in a single forum for discussions and resolutions. No more manual merging of Word track changes.
Efficient, flexible changemanagement
Real-time automatic notifications are sent when reused content changes. Quickly view changes and update local documents appropriately.
Quick and easy publishing tomultiple channels
Create different document types (Word, PDF, HTML, etc.) with different styles from a single project. Automatically upload to existing downstream system.
Robust, detailed reportingand audit trail
All content updates, reviews, approval workflows and publishing events are captured and stored in the Docuvera audit trail. Document reasons for changes and content deviations as part of the change management process.
Docuvera For
Clinical
Docuvera brings efficient and easy-to-use component-based authoring capabilities to the creation of and revision process for pre-clinical and clinical content.
Global Labeling
Docuvera’s end-to-end solution reduces labeling content production times, ensures alignment to compliant content, and creates faster time-to-market for regulatory submissions.
Medical Information
Docuvera reduces medinfo content production times and enables omnichannel distribution of medical content to health care professionals.
Chemistry Manufacturing and Controls
Docuvera enables the efficient creation and maintenance of CMC documentation by reusing core component content to assemble local documentation.
Chemistry Manufacturing and Controls
Docuvera enables the efficient creation and maintenance of CMC documentation by reusing core component content to assemble local documentation.
Aggregate Reporting and Safety Writing
Docuvera brings component-based reuse to the creation and maintenance of aggregate safety reports for all stages of the product lifecycle.
Quality Documents/SOPs
Review, approve, translate, reuse and publish quality documents and reuse approved content components to efficiently assemble accurate SOPs with Docuvera.